您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Tivantinib(ARQ-197)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Tivantinib(ARQ-197)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Tivantinib(ARQ-197)图片
CAS NO:905854-02-6
包装:2mg, 5mg, 10mg, 25mg
包装与价格:
包装价格(元)
Free Sample (0.5-1 mg)电议
10mM*1mL in DMSO电议
2mg电议
5mg电议
10mg电议
25mg电议

产品名称
Tivantinib, ARQ197
产品介绍

生物活性

Tivantinib (ARQ 197)是第一个非ATP竞争性的c-Met抑制剂,Ki为0.355 μM,对Ron几乎没有作用活性,对EGFR, InsR, PDGFRα和FGFR1/4没有抑制作用。Tivantinib (ARQ 197) 抑制HGF/c-met诱导的细胞反应。Tivantinib (ARQ 197) 具有抗肿瘤活性,抑制A549, DBTRG和NCI-H441细胞增殖,IC50分别为0.38, 0.45, 0.29 μM。用ARQ-197处理,导致MAPK信号级联放大磷酸化降低,且阻断入侵和迁移。


化学数据

分子量369.42
分子式C23H19N3O2
CAS号905854-02-6
纯度100.00%
溶解性(25°C)DMSO 64 mg/mL
储存和运输条件固体粉末: -20°C 冷藏长期储存
常温运输及临时存放

实验操作 来自于公开的文献,仅供相同实验参考(如实验材料、目的不同,请参考其他文献)

细胞实验
细胞系SK-MEL-28, NCI-H661, NCI-H446, DLD-1, A549, SK-OV-3, NCI-H460, A375, NCI-H441, HT29, MKN-45, and MDA-MB-231 cells
方法Cell proliferation assay
Cells were seeded in 96-well plates overnight in a medium with 10% FBS. Each cell line was optimized for seeding cell number to ensure a similar degree of confluence at the end of the experiment in nontreated (control) wells. The next day, cells were treated with different concentrations of ARQ 197 for 24 hours at 37°C. After ARQ 197 treatment, the drug-containing medium was removed, and cells were washed twice with PBS and incubated in a drug-free medium for an additional 48 hours. Cells were then incubated and stained for 4 hours with the MTS reagent (final concentration of 0.5 mg/mL; Promega) per well and were lysed. The results were quantitated by spectrophotometry at λ = 450 nm.
浓度0.03–10 μmol/L
处理时间24 h

动物实验
动物模型athymic mice bearing HT29, MKN-45, or MDA-MB-231 tumor xenografts
配制polyethylene glycol 400/20% Vitamin E tocopheryl polyethylene glycol succinate (60:40) at 30 mg/mL
剂量200 mg/kg for 5 consecutive days weekly for four cycles
给药处理orally

不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)

小鼠大鼠豚鼠仓鼠
重量 (kg)0.020.151.80.40.0810
体表面积 (m2)0.0070.0250.150.050.020.5
Km系数36128520
动物 A (mg/kg) = 动物 B (mg/kg) × 动物 B的Km系数
动物 A的Km系数

例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。


储备液配制

以下数据基于产品分子量,对于特殊产品,请参照COA中的储备液配制条件和说明进行操作。

Concentration / Solvent Volume / Mass1 mg5 mg10 mg
1 mM2.7069 mL13.5347 mL27.0695 mL
5 mM0.5414 mL2.7069 mL5.4139 mL
10 mM0.2707 mL1.3535 mL2.7069 mL